XFOR (X4 Pharmaceuticals, Inc.) Wutah dodolan kuartal marang kuartal

Logo grafis X4 Pharmaceuticals (XFOR)

X4 Pharmaceuticals is at the peak of recognition due to the success of XOLREMDI in treating WHIM syndrome. Quarterly sales growth helps track this trend, where the value of 63.10 reflects the metric's balance. The company is integrating ESG standards and bioethics into its production. The business's future relies on regulatory approvals and insurance coverage for new immunological developments targeting rare pathologies.

Wutah pendapatan kuartal marang kuartal: X4 Pharmaceuticals, Inc. (XFOR) kanggo 04.07.2022 - 20.11.2026

Ringkesan rincian data analitis X4 Pharmaceuticals, Inc. (XFOR)

Pambiji fundamental perusahaan:XFOR X4 Pharmaceuticals
Produk mawa merek x4pharma.com

Institutional capital evaluates X4 Pharmaceuticals (XFOR) through the lens of the commercial launch efficiency of its first drug, where the pace of expansion across US clinics determines its investment attractiveness. The magnitude of quarterly revenue growth measures the percentage change in sales relative to the previous period, allowing investors to verify cash flow sustainability and confirm the asset's reliability during the organic business scaling phase.

Analisis pesaing X4 Pharmaceuticals

argenx BVBA - Wutah pendapatan triwulanan|BNTX: Wutah pendapatan kuartal marang kuartal|ABVX: Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ADMA|Wutah pendapatan kuartal marang kuartal protagonist-inc.com|Wutah dodolan triwulanan Immunovant, Inc. (IMVT)|Wutah pendapatan triwulanan KNSA|GRFS: Dinamika pendapatan kuartal marang kuartal|Adaptive Biotechnologies - Wutah dodolan triwulanan|CLDX: Wutah dodolan kuartal marang kuartal|Aurinia Corp - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal BioCryst Corp|VERA: Wutah pendapatan triwulanan|dianthustx.com (DNTH) - Wutah pendapatan triwulanan|PHVS (Pharvaris NV) - Wutah pendapatan triwulanan|ABCL: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Tourmaline Bio, Inc. (TRML)|PGEN (Intrexon) - Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan PHAR (Pharming Corp)|nektar.com (NKTR) - Tingkat wutah pendapatan sajrone kuartal|UPB - Wutah pendapatan kuartal marang kuartal|Tambahing pendapatan triwulanan ZBIO (Zenas Biopharma)|IMNM: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Gossamer Bio, Inc. (GOSS)|Wutah pendapatan kuartal marang kuartal KalVista Pharmaceuticals|Septerna Inc (SEPN) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan PVLA|SVRA (Savara) - Tambahing pendapatan triwulanan|Rigel Pharma - Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal AnaptysBio Corp (ANAB)|ATXS: Wutah dodolan triwulanan|Tambahing pendapatan triwulanan ENGN (enGene Holdings Inc.)|RAPT Therapeutics Inc. (RAPT) - Wutah pendapatan kuartal marang kuartal|Aerovate Therapeutics Inc (JBIO) - Wutah pendapatan triwulanan|ACRS (Aclaris Therapeutics, Inc) - Wutah pendapatan triwulanan|Kyverna (KYTX) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan TLSA|Wutah dodolan triwulanan Cabaletta Bio, Inc. CABA|Ventyx Biosciences - Wutah dodolan triwulanan|THTX: Wutah dodolan kuartal marang kuartal|AVTX - Wutah pendapatan kuartal marang kuartal|ELDN: Wutah pendapatan kuartal marang kuartal|Agenus Inc. (AGEN) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan triwulanan Climb Bio Inc|ZURA (Zura Bio Ltd) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan aTyr Pharma Inc|Wutah pendapatan triwulanan ADAG|Tingkat wutah dodolan sajrone kuartal ImageneBio|Wutah pendapatan triwulanan STTK (Shattuck Labs Inc)|Wutah pendapatan triwulanan Equillium, Inc. EQ|CNTB - Wutah pendapatan kuartal marang kuartal|Immunic Therapeutics (IMUX) - Wutah dodolan triwulanan|ATRA: Wutah pendapatan triwulanan|InflaRx GmbH (IFRX) - Wutah pendapatan triwulanan|ACET (Adicet) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan celularity.com (CELU)|Wutah pendapatan kuartal marang kuartal INmune Bio Inc (INMB)|Tingkat wutah dodolan sajrone kuartal Barinthus Biotherapeutics PLC|Wutah pendapatan kuartal marang kuartal Kezar Life Sciences Inc KZR|Tambahing pendapatan triwulanan SABS|AKTX - Wutah pendapatan kuartal marang kuartal|Tambahing pendapatan triwulanan ENLV (enlivex.com)|QTTB: Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal GOVX|Wutah dodolan triwulanan EDSA|Wutah dodolan kuartal marang kuartal IBIO (iBio Corp)|Wutah pendapatan kuartal marang kuartal Carisma Therapeutics Inc (CARM)|Tingkat wutah dodolan sajrone kuartal xtlbio.com|Bolt Biotherapeutics Inc. - Wutah dodolan triwulanan|HCW Biologics Inc (HCWB) - Tingkat wutah pendapatan sajrone kuartal|Aptevo - Wutah pendapatan triwulanan|AIM ImmunoTech (AIM) - Wutah dodolan triwulanan|Aditxt Corp (ADTX) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal GRI|Wutah dodolan triwulanan XRTX|Tingkat wutah pendapatan sajrone kuartal Vyome Holdings Inc. HIND|Wutah pendapatan triwulanan REVB|Tingkat wutah dodolan sajrone kuartal Indaptus Corp|BiondVax Pharmaceuticals - Wutah dodolan triwulanan|CalciMedica Corp (CALI) - Tingkat wutah pendapatan sajrone kuartal|Affimed - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal allakos.com ALLK|HOOKIPA Pharma (HOOK) - Wutah pendapatan kuartal marang kuartal|IGMS (IGM Biosciences Inc.) - Wutah pendapatan kuartal marang kuartal|ITOS (iTeos Therapeutics) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal OCEA (Ocean Biomedical)|Wutah pendapatan kuartal marang kuartal TC Biopharm (TCBP)|THRD (Third Harmonic Bio Inc.) - Tambahing pendapatan triwulanan